A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, ...
In the rapidly evolving landscape of modern biotechnology, the precision of molecular tools determines the speed of medical breakthroughs. As a Global Leading Biotinylated Peptide Synthesis specialist ...
A biotech start-up says the ovaries may hold clues to aging — a finding that could reshape IVF while opening a frontier in ...
According to Gartner, 58% of finance functions employed AI in 2024—a 21-percentage-point jump from the prior year. PwC ...
NIH agrees to reevaluate research projects left in bureaucratic limbo while a lawsuit over termination of DEI-related grants ...
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
Mineralys (MLYS) is transitioning to a pre-commercial stage, supported by robust Phase 3 data and a strengthened cash ...
The biotech firm focused on fighting breast cancer was recently selected to the prestigious Charles River Cell & Gene Therapy ...
The company plans to announce Phase 1b interim data by mid-2026, and the TENACITY-01 study is expected to be completed by late 2028. This timing enables progression to Phase 2 evaluation following ...
Under the ongoing collaboration Remedy Cell’s personnel, along with Pluri’s Contract Development and Manufacturing Organization (“CDMO”) division (PluriCDMO™), have successfully completed the full ...
The Cadillac CT5-V Blackwing is produced at GM’s Lansing Grand River Assembly plant with a unique V8 and manual transmission ...
The independent journey of CureVac as a publicly traded company has reached its conclusion. Following the expiration of the acceptance period, BioNTech has s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback